At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
INN Summit Hotel Properties
Closed Good Friday 04-17 16:00:00 EDT
3.92
+0.06
+1.55%
盘后3.92
+0.000.00%
18:14 EDT
| High4.00 | Low3.87 | Vol734.74K |
| Open3.87 | D1 Closing3.86 | Amplitude3.24% |
| Mkt Cap430.34M | Tradable Cap378.40M | Total Shares109.78M |
| T/O2.88M | T/O Rate0.76% | Tradable Shares96.53M |
| P/B0.47 | ROE2.80% | EPS0.22 |
| 52wk High7.22 | 52wk Low3.57 | P/E17.80 |
| Dividend0.30 | Div.Yield0.08 | ROA1.74% |
Loading ...
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
GlobeNewswire · 04-15 22:37
Innocan Pharma Announces Closing of Private Placement
CNW Group · 04-15
Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units
CNW Group · 04-07
Remsense Technologies Teams Up With Investor-Focused News Platform; Shares Down 12%
MT Newswires Live · 04-03
How Much Would It Take To Earn $100 A Month From Summit Hotel Properties Stock
Benzinga · 04-03
BRIEF-Summit Hotel Properties Completes $275 Million Delayed Draw Term Loan Financing
Reuters · 03-31
Summit Hotel Properties Completes $275 Million Delayed Draw Term Loan Financing
THOMSON REUTERS · 03-31
Press Release: SUMMIT HOTEL PROPERTIES COMPLETES $275 MILLION DELAYED DRAW TERM LOAN FINANCING
Dow Jones · 03-31
Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million
CNW Group · 03-31
Press Release: Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results
Dow Jones · 03-31
Press Release: SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update
Dow Jones · 03-20
LGVN Announces Positive Alzheimer’s News
Zacks Small Cap Research · 03-20
INN or NHI: Which Is the Better Value Stock Right Now?
Zacks · 03-14
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer’s Disease
GlobeNewswire · 03-11
Innocan Pharma Announces Closing of Debenture Unit Offering to its Largest Shareholder, Tamar Innovest Limited
CNW Group · 03-07
Chemomab Therapeutics Announces Year End and Fourth Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire · 03-03
LGVN Well Positioned for Critical 2025
Zacks Small Cap Research · 03-03
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update
GlobeNewswire · 02-28
Press Release: Longeveron(R) Announces Full-Year 2024 Financial Results and Provides Business Update
Dow Jones · 02-28
Innocan Pharma Announces Private Placement Offering of a Debenture Unit to its Largest Shareholder, Tamar Innovest
CNW Group · 02-27
Introduction
Company Name.
Summit Hotel Properties
Affiliated Markets:
NYSE
Listing Date:
2011-02-09
Main Business:
Summit Hotel Properties, Inc. is a publicly traded real estate investment trust focused on owning premium-branded lodging properties with efficient operating models primarily in the upscale segment of the lodging industry. As of November 1, 2023, the Company's portfolio consisted of 101 assets, 57 of which are wholly owned, with a total of 15,035 guestrooms located in 24 states.
Issue price:
9.75
Invest in Global Markets with Tiger Brokers!Open App